The Bavarian Nordic shot has not undergone clinical trials to evaluate the vaccine's ability to prevent monkeypox in humans, though initial studies suggest it will provide some protection
A smaller dose of the monkeypox vaccine appears to still be effective and can be used to stretch the current supply by five times, the European Medicines Agency said Friday, echoing a recommendation made earlier this month by the US Food and Drug Administration. The EU drug regulator said in a statement that injecting people with just one fifth the regular dose of the smallpox vaccine made by Bavarian Nordic appeared to produce similar levels of antibodies against monkeypox as a full dose. The approach calls for administering Bavarian Nordic's vaccine with an injection just under the skin rather than into deeper tissue, a practice that may stimulate a better immune response. People still need to get two doses, about four weeks apart. The EMA said national authorities could decide, as a temporary measure to use smaller doses of the vaccine to protect vulnerable people during the ongoing monkeypox outbreak. EU health commissioner Stella Kyriakides said the decision would allow the ..
Finance Minister Nirmala Sitharaman on Wednesday said nearly 60 per cent of all the vaccines used in the world are produced in India and over the decades, the country has made remarkable contribution to vaccinating the world. India today is double dosing every citizen and produced COVID-19 vaccines even during the lockdown period, she added. Launching the book 'India's Vaccine Growth Story' by Sajjan Singh Yadav, Additional Secretary, Expenditure Department, Sitharaman said it is in the country's DNA to be able to contribute to world vaccination. "Over the decades India has made remarkable contribution. Nearly 60 per cent of all the vaccines which are used in the world are produced in India. India has singular contribution to make to the world in terms of vaccination and that which is being produced and supplied to the entire world," Sitharaman said. Today, the country is double dosing every citizen, she said, adding it is not easy to produce and execute COVID vaccination at that .
State governments, as well as e-commerce players, are taking initiatives to launch healthcare services through drones into remote areas
Among the companies that are working with ICMR are Serum Institute of India (SII), Reliance Life Sciences, Dr Reddy's Laboratories, and Biological E
Although the smallpox jab has shown to reduce the chance of symptomatic infection and severe illness from monkeypox, protection may decline over time.
In June, the UK Health Security Agency reported that polio virus had been detected in sewage in north and east London post which vaccine boosters were offered.
The Hyderabad-based company claimed that BBV154 is proven to be safe, well-tolerated and immunogenic in the subjects under controlled clinical trials
The Health Security Agency said authorities are reporting about 29 new monkeypox infections every day, compared to about 52 cases a day during the last week in June.
British authorities also said that they bought as many as 150,000 doses of the vaccine, which was made by Bavarian Nordic, the world's only supplier
SII is working with Novavax to bring the Omicron-specific vaccine, as the nation continues to record a surge in the number of Covid-19 cases
ICMR has received 31 bids from manufacturers showing interest in developing vaccine and diagnostic kits against the monkeypox virus after the medical body floated the Expression of Interest (EOI)
Plans afoot to seek regulator nod for universal boosters
There are no discussions with the private sector because all available doses have already been bought by countries, he said.
Health ministry nod to the Biological E vaccine as 3rd dose after Covishield or Covaxin, CoWIN to be updated within a week
The Pune-based company that manufactured the Covid-19 vaccine administered to most Indians is exploring more sophisticated delivery systems
India's Vaccine Growth Story: From Cowpox to Vaccine Maitri is divided into nine chapters with an epilogue
With non-endemic countries reporting a rampant spike in the number of monkeypox cases, WHO on July 24, 2022, declared monkeypox a global health emergency
Adar Poonawalla has taken Indian vaccines to the US and European markets. In an interview with Business Standard's Sohini Das, he tells about his plans for mass production of vaccines and more
The Union health ministry issued the 'Guidelines on Management of Monkeypox Disease' and stated that human-to-human transmission occurs primarily through large respiratory droplets